New Approach to Use Phage Therapy against Aeromonas hydrophila Induced Motile Aeromonas Septicemia in Nile Tilapia
- Corresponding Author:
- El-Araby DA
Department of Fish Diseases and Management
Central Laboratory of Aquaculture Research Center Ponds of Abbassa
Abou-Hammad, Sharkia, Egypt
E-mail: [email protected]
Received Date: May 07, 2016; Accepted Date: May 28, 2016; Published Date: May 31, 2016
Citation: El-Araby DA, El-Didamony G, Megahed MTH (2016) New Approach to Use Phage Therapy against Aeromonas hydrophila Induced Motile Aeromonas Septicemia in Nile Tilapia. J Marine Sci Res Dev 6:194. doi:10.4172/2155-9910.1000194
Copyright: © 2016 El-Araby DA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Infections with Aeromonas hydrophila is a progressive problem in aquaculture. The use of antibiotic such as Ciprofloxacine has contributed to the rapid and effective treatment of disease cause by this organism. However the Fast-paced increase of resistance to the Said antibiotics has posed problems and there is now a new approach to look for alternative method to control this bacterial pathogen. Phage therapy comes in as a new method to respond to these growing problems. This study demonstrated the promising action of isolated bacteriophage ΦZH1 and ΦZH2 for therapy against Motile Aeromonas Septicemia in Nile tilapia caused by Aeromonas hydrophila.